Hyperkalemia accompanies hemorrhagic shock and correlates with mortality
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/18061 |
Resumo: | OBJECTIVE: This study was designed to evaluate the effects of terlipressin versus fluid resuscitation with normal saline, hypertonic saline or hypertonic-hyperoncotic hydroxyethyl starch, on hemodynamics, metabolics, blood loss and short-term survival in hemorrhagic shock. METHOD: Twenty-nine pigs were subjected to severe liver injury and treated 30 min later with either: (1) 2 mg terlipressin in a bolus, (2) placebo-treated controls, (3) 4 mL/kg 7.5% hypertonic NaCl, (4) 4 mL/kg 7.2% hypertonic-hyperoncotic hydroxyethyl starch 200/0.5, or (5) normal saline at three times lost blood volume. RESULTS: The overall mortality rate was 69%. Blood loss was significantly higher in the hypertonic-hyperoncotic hydroxyethyl starch and normal saline groups than in the terlipressin, hypertonic NaCl and placebo-treated controls groups (p;5 mmol/L) before any treatment occurred in 66% of the patients (80% among non-survivors vs. 22% among survivors, p=0.019). Post-resuscitation hyperkalemia occurred in 86.66% of non-survivors vs. 0% of survivors (p |
id |
USP-19_c0f371aa515b3f1154e5f2f27f0bbbd2 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/18061 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Hyperkalemia accompanies hemorrhagic shock and correlates with mortality Hemorrhagic ShockHyperkalemiaCardiac ArrestMortalityTrauma OBJECTIVE: This study was designed to evaluate the effects of terlipressin versus fluid resuscitation with normal saline, hypertonic saline or hypertonic-hyperoncotic hydroxyethyl starch, on hemodynamics, metabolics, blood loss and short-term survival in hemorrhagic shock. METHOD: Twenty-nine pigs were subjected to severe liver injury and treated 30 min later with either: (1) 2 mg terlipressin in a bolus, (2) placebo-treated controls, (3) 4 mL/kg 7.5% hypertonic NaCl, (4) 4 mL/kg 7.2% hypertonic-hyperoncotic hydroxyethyl starch 200/0.5, or (5) normal saline at three times lost blood volume. RESULTS: The overall mortality rate was 69%. Blood loss was significantly higher in the hypertonic-hyperoncotic hydroxyethyl starch and normal saline groups than in the terlipressin, hypertonic NaCl and placebo-treated controls groups (p;5 mmol/L) before any treatment occurred in 66% of the patients (80% among non-survivors vs. 22% among survivors, p=0.019). Post-resuscitation hyperkalemia occurred in 86.66% of non-survivors vs. 0% of survivors (pHospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2009-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1806110.1590/S1807-59322009000600016Clinics; Vol. 64 No. 6 (2009); 591-597 Clinics; v. 64 n. 6 (2009); 591-597 Clinics; Vol. 64 Núm. 6 (2009); 591-597 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/18061/20125Rocha Filho, Joel AvanciniNani, Ricardo SouzaD'Albuquerque, Luiz Augusto CarneiroHolms, Carla AugustoRocha, João Plínio SouzaMalbouisson, Luís Marcelo SáMachado, Marcel Cerqueira CésarCarmona, Maria José CarvalhoAuler Júnior, José Otávio Costainfo:eu-repo/semantics/openAccess2012-05-22T18:53:49Zoai:revistas.usp.br:article/18061Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-22T18:53:49Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Hyperkalemia accompanies hemorrhagic shock and correlates with mortality |
title |
Hyperkalemia accompanies hemorrhagic shock and correlates with mortality |
spellingShingle |
Hyperkalemia accompanies hemorrhagic shock and correlates with mortality Rocha Filho, Joel Avancini Hemorrhagic Shock Hyperkalemia Cardiac Arrest Mortality Trauma |
title_short |
Hyperkalemia accompanies hemorrhagic shock and correlates with mortality |
title_full |
Hyperkalemia accompanies hemorrhagic shock and correlates with mortality |
title_fullStr |
Hyperkalemia accompanies hemorrhagic shock and correlates with mortality |
title_full_unstemmed |
Hyperkalemia accompanies hemorrhagic shock and correlates with mortality |
title_sort |
Hyperkalemia accompanies hemorrhagic shock and correlates with mortality |
author |
Rocha Filho, Joel Avancini |
author_facet |
Rocha Filho, Joel Avancini Nani, Ricardo Souza D'Albuquerque, Luiz Augusto Carneiro Holms, Carla Augusto Rocha, João Plínio Souza Malbouisson, Luís Marcelo Sá Machado, Marcel Cerqueira César Carmona, Maria José Carvalho Auler Júnior, José Otávio Costa |
author_role |
author |
author2 |
Nani, Ricardo Souza D'Albuquerque, Luiz Augusto Carneiro Holms, Carla Augusto Rocha, João Plínio Souza Malbouisson, Luís Marcelo Sá Machado, Marcel Cerqueira César Carmona, Maria José Carvalho Auler Júnior, José Otávio Costa |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Rocha Filho, Joel Avancini Nani, Ricardo Souza D'Albuquerque, Luiz Augusto Carneiro Holms, Carla Augusto Rocha, João Plínio Souza Malbouisson, Luís Marcelo Sá Machado, Marcel Cerqueira César Carmona, Maria José Carvalho Auler Júnior, José Otávio Costa |
dc.subject.por.fl_str_mv |
Hemorrhagic Shock Hyperkalemia Cardiac Arrest Mortality Trauma |
topic |
Hemorrhagic Shock Hyperkalemia Cardiac Arrest Mortality Trauma |
description |
OBJECTIVE: This study was designed to evaluate the effects of terlipressin versus fluid resuscitation with normal saline, hypertonic saline or hypertonic-hyperoncotic hydroxyethyl starch, on hemodynamics, metabolics, blood loss and short-term survival in hemorrhagic shock. METHOD: Twenty-nine pigs were subjected to severe liver injury and treated 30 min later with either: (1) 2 mg terlipressin in a bolus, (2) placebo-treated controls, (3) 4 mL/kg 7.5% hypertonic NaCl, (4) 4 mL/kg 7.2% hypertonic-hyperoncotic hydroxyethyl starch 200/0.5, or (5) normal saline at three times lost blood volume. RESULTS: The overall mortality rate was 69%. Blood loss was significantly higher in the hypertonic-hyperoncotic hydroxyethyl starch and normal saline groups than in the terlipressin, hypertonic NaCl and placebo-treated controls groups (p;5 mmol/L) before any treatment occurred in 66% of the patients (80% among non-survivors vs. 22% among survivors, p=0.019). Post-resuscitation hyperkalemia occurred in 86.66% of non-survivors vs. 0% of survivors (p |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/18061 10.1590/S1807-59322009000600016 |
url |
https://www.revistas.usp.br/clinics/article/view/18061 |
identifier_str_mv |
10.1590/S1807-59322009000600016 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/18061/20125 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 64 No. 6 (2009); 591-597 Clinics; v. 64 n. 6 (2009); 591-597 Clinics; Vol. 64 Núm. 6 (2009); 591-597 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222754790703104 |